Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Dmitry N. Shcherbinin"'
Autor:
Tatiana A. Timofeeva, Irina A. Rudneva, Natalia F. Lomakina, Elena B. Timofeeva, Irina M. Kupriyanova, Alexsander V. Lyashko, Dmitry N. Shcherbinin, Alexsander A. Shilov, Maksim M. Shmarov, Elena L. Ryazanova, Larisa V. Mochalova, Boris I. Timofeev
Publikováno v:
Microbiology Independent Research Journal, Vol 8, Iss 1, Pp 50-61 (2021)
Avian influenza viruses of the H1 and H5 subtypes were involved in the formation of highly pathogenic viruses that caused pandemics and panzootics in the 20th–21st centuries. In order to assess the zoonotic potential of viruses of these subtypes, t
Externí odkaz:
https://doaj.org/article/325d1ccf6e68459a97959f7da305837b
Autor:
Amir I. Tukhvatulin, Inna V. Dolzhikova, Dmitry V. Shcheblyakov, Olga V. Zubkova, Alina S. Dzharullaeva, Anna V. Kovyrshina, Nadezhda L. Lubenets, Daria M. Grousova, Alina S. Erokhova, Andrei G. Botikov, Fatima M. Izhaeva, Olga Popova, Tatiana A. Ozharovskaia, Ilias B. Esmagambetov, Irina A. Favorskaya, Denis I. Zrelkin, Daria V. Voronina, Dmitry N. Shcherbinin, Alexander S. Semikhin, Yana V. Simakova, Elizaveta A. Tokarskaya, Maksim M. Shmarov, Natalia A. Nikitenko, Vladimir A. Gushchin, Elena A. Smolyarchuk, Tatiana G. Zubkova, Konstantin A. Zakharov, Vasiliy B. Vasilyuk, Sergei V. Borisevich, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
The Lancet Regional Health. Europe, Vol 11, Iss , Pp 100241- (2021)
Background: While the world is experiencing another wave of COVID-19 pandemic, global vaccination program is hampered by an evident shortage in the supply of licensed vaccines. In an effort to satisfy vaccine demands we developed a new single-dose va
Externí odkaz:
https://doaj.org/article/54fc97d8b69745aa9da8b8b6bf909e3d
Autor:
Daria A Burmistrova, Sergey V Tillib, Dmitry V Shcheblyakov, Inna V Dolzhikova, Dmitry N Shcherbinin, Olga V Zubkova, Tatiana I Ivanova, Amir I Tukhvatulin, Maxim M Shmarov, Denis Y Logunov, Boris S Naroditsky, Aleksandr L Gintsburg
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0150958 (2016)
Developing pathogen-specific recombinant antibody fragments (especially nanobodies) is a very promising strategy for the treatment of infectious disease. Nanobodies have great potential for gene therapy application due to their single-gene nature. Hi
Externí odkaz:
https://doaj.org/article/164c15adc31444e6ab091391e560d24e
Autor:
Daria V. Voronina, Dmitry V. Shcheblyakov, Ilias B. Esmagambetov, Artem A. Derkaev, Olga Popova, Dmitry N. Shcherbinin
Publikováno v:
Acta Naturae
The influenza virus infection claims ~650,000 lives annually. Taking into account the evolving resistance of the pathogen to antiviral drugs and the waning effectiveness of vaccination among certain populations, new approaches to the treatment of inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30988288ce2c5a6886a731f06451616d
https://pubmed.ncbi.nlm.nih.gov/35127144
https://pubmed.ncbi.nlm.nih.gov/35127144
Autor:
A. I. Tukhvatulin, Fatima M. Izhaeva, Denis Y. Logunov, Daria A. Egorova, Daria M. Grousova, Andrei G. Botikov, Alina S. Dzharullaeva, Sergei V. Borisevich, Olga Popova, Denis I. Zrelkin, Ilias B Esmagambetov, Alexander S. Semikhin, Daria V Voronina, Elena A Smolyarchuk, Dmitry N. Shcherbinin, Olga V. Zubkova, Nadezhda L. Lubenets, M M Shmarov, Anna V. Kovyrshina, Tatiana A Ozharovskaya, Boris S. Naroditsky, Dmitry V. Shcheblyakov, Inna V. Dolzhikova, Alexander L. Gintsburg, Irina A Favorskaya, Alina S. Erokhova, Natalia A. Nikitenko, Vladimir A. Gushchin, Sergey Zyryanov, Yana V. Simakova, Elizaveta A. Tokarskaya
Publikováno v:
The Lancet
Lancet (London, England)
Lancet (London, England)
Background A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), showed a good safety profile and induced strong humoral and cellular immune responses in participants in phase 1/2 clinical trials. Here, we report preli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45be4c8958b8b211911b441dc840d66e
Autor:
Amir I. Tukhvatulin, Inna V. Dolzhikova, Dmitry V. Shcheblyakov, Olga V. Zubkova, Alina S. Dzharullaeva, Anna V. Kovyrshina, Nadezhda L. Lubenets, Daria M. Grousova, Alina S. Erokhova, Andrei G. Botikov, Fatima M. Izhaeva, Olga Popova, Tatiana A. Ozharovskaia, Ilias B. Esmagambetov, Irina A. Favorskaya, Denis I. Zrelkin, Daria V. Voronina, Dmitry N. Shcherbinin, Alexander S. Semikhin, Yana V. Simakova, Elizaveta A. Tokarskaya, Maksim M. Shmarov, Natalia A. Nikitenko, Vladimir A. Gushchin, Elena A. Smolyarchuk, Tatiana G. Zubkova, Konstantin A. Zakharov, Vasiliy B. Vasilyuk, Sergei V. Borisevich, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
SSRN Electronic Journal.
Background: While the world is experiencing another wave of COVID-19 pandemic, global vaccination program is hampered by obvious shortage in supply of licensed vaccines. Development of new vaccines that are easy to manufacture and administer is highl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46dd4f7e36c0425bc50de16bb4665594
https://doi.org/10.2139/ssrn.3886430
https://doi.org/10.2139/ssrn.3886430
Autor:
Andrey Aleksandrovich Lysenko, Alexander Bagaev, Pichugin Av, Denis Y. Logunov, Ilias B Esmagambetov, Boris S. Naroditsky, Ataullakhanov Ravshan I, Maxim M. Shmarov, E S Sedova, I. L. Tutykhina, Alexander L. Gintsburg, Dmitry N. Shcherbinin
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 1, p e0191574 (2018)
PLoS ONE, Vol 13, Iss 1, p e0191574 (2018)
To avoid outbreaks of influenza virus epidemics and pandemics among human populations, modern medicine requires the development of new universal vaccines that are able to provide protection from a wide range of influenza A virus strains. In the cours
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dda2a79279c608e86499a8bd698f6a15
https://pubmed.ncbi.nlm.nih.gov/29377916
https://pubmed.ncbi.nlm.nih.gov/29377916
Autor:
Aleksandr Leonidovich Gintsburg, Maxim M. Shmarov, Dmitry V. Shcheblyakov, Boris S. Naroditsky, A. I. Tukhvatulin, Daria A. Burmistrova, Dmitry N. Shcherbinin, Inna V. Dolzhikova, Sergey V. Tillib, Olga V. Zubkova, Denis Y. Logunov, Tatiana I. Ivanova
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 3, p e0150958 (2016)
PLoS ONE, Vol 11, Iss 3, p e0150958 (2016)
Developing pathogen-specific recombinant antibody fragments (especially nanobodies) is a very promising strategy for the treatment of infectious disease. Nanobodies have great potential for gene therapy application due to their single-gene nature. Hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cb21c335bfa2358a33cbaa0713d7aaf
http://europepmc.org/articles/PMC4786110
http://europepmc.org/articles/PMC4786110
Autor:
Tatiana A Ozharovskaya, Nadezhda L. Lubenets, Sergei V. Borisevich, Alexander S. Semikhin, Daria M. Grousova, Andrei G. Botikov, Yana V. Simakova, Fatima M. Izhaeva, Alina S. Erokhova, Denis I. Zrelkin, Olga V. Zubkova, Irina A Favorskaya, Elena A Smolyarchuk, Boris S. Naroditsky, M M Shmarov, Natalia A. Nikitenko, Alina S. Dzharullaeva, Alexander L. Gintsburg, Morozova Lf, Daria A. Egorova, Evgeny V Kryukov, Dmitry V. Shcheblyakov, Olga Popova, Denis Y. Logunov, Dmitry N. Shcherbinin, Inna V. Dolzhikova, Amir I Tukhvatullin, Elizaveta A. Tokarskaya, Ilias B Esmagambetov, Vladimir F Babira, Anna V. Kovyrshina, Daria V Voronina
Publikováno v:
Yana Simakova
Lancet (London, England)
The Lancet
Lancet (London, England)
The Lancet
Summary Background We developed a heterologous COVID-19 vaccine consisting of two components, a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (rAd5) vector, both carrying the gene for severe acute respiratory syndr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b04ada67ad427528778d88936c6006e
